What must happen before an applicant with a primary or secondary malignant disease can have their application further considered?

The applicant must undergo satisfactory oncological evaluation before further consideration is given to their application.

For a class 1 medical certificate, what is the required process for an applicant with a malignant disease?

The applicant must be referred to the medical assessor of the licensing authority.

MED.B.090 Oncology

Q: How is an applicant with a malignant disease for a class 2 medical certificate assessed?

The applicant must be assessed in consultation with the medical assessor of the licensing authority.

Q: What is the assessment outcome for an applicant with a documented medical history or clinical diagnosis of an intracerebral malignant tumour?

The applicant shall be assessed as unfit.

Navigate / EASA

Ask question Discover more Add to collection

MED.B.090 Oncology

Regulation (EU) 2019/27

(a) Before further consideration is given to their application, applicants with primary or secondary malignant disease shall undergo satisfactory oncological evaluation. Such applicants for a class 1 medical certificate shall be referred to the medical assessor of the licensing authority. Such applicants for a class 2 medical certificate shall be assessed in consultation with the medical assessor of the licensing authority.

(b) Applicants with a documented medical history or clinical diagnosis of an intracerebral malignant tumour shall be assessed as unfit.

Details

Source-Title: MED.B.090 Oncology View latest amendments

Erulesid: ERULES-1963177438-11125 Compare versions

Domain: Aircrew

Applicabilitydate: 30 January, 2019

Entryintoforcedate: 30 January, 2019

Regulatorysource: Regulation (EU) 2019/27 Navigate

Regulatorysubject: Part-MED

Typeofcontent: IR (Implementing rule)

Origin: EASA

Category: EAR

MED.B.090 Oncology

Details

Related sections: